Curaleaf Wants to Buy Aurora Cannabis for $272 Million. Is Canopy Growth the Next Marijuana Takeover Target?
Cannabis consolidation appears to be accelerating.
Curaleaf, the U.S. cannabis giant, has made an unsolicited bid of $272 million to acquire Aurora Cannabis, marking a potential shift in the consolidation trend within the industry. The $4 per share offer represents a 45% premium over Aurora's 30-day volume-weighted average price. Curaleaf anticipates the merger could yield annual revenues of $1.5 billion, $350 million in adjusted EBITDA, and at least $40 million in annual cost synergies.
However, this move raises the question of whether Canopy Growth, another major player, could also be a takeover target. While Canopy has been working on its own turnaround, including debt reduction, exiting non-core businesses, and focusing on higher-margin medical cannabis, it remains to be seen if the cannabis industry will extend its consolidation efforts to include this prominent company.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
